Kukulka, M., Nudurupati, S., & Perez, M. C. (2016). Bioavailability, safety, and pharmacodynamics of delayed-release dexlansoprazole administered as two 30 mg orally disintegrating tablets or one 60 mg capsule. Therap Adv Gastroenterol.
Citación estilo ChicagoKukulka, Michael, Sai Nudurupati, and Maria Claudia Perez. "Bioavailability, Safety, and Pharmacodynamics of Delayed-release Dexlansoprazole Administered As Two 30 Mg Orally Disintegrating Tablets or One 60 Mg Capsule." Therap Adv Gastroenterol 2016.
Cita MLAKukulka, Michael, Sai Nudurupati, and Maria Claudia Perez. "Bioavailability, Safety, and Pharmacodynamics of Delayed-release Dexlansoprazole Administered As Two 30 Mg Orally Disintegrating Tablets or One 60 Mg Capsule." Therap Adv Gastroenterol 2016.